• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

始终领先一步:致病菌如何利用 III 型分泌系统来操纵肠道黏膜免疫系统。

Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system.

机构信息

Centre for Immunology and Infectious Disease, Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, UK.

出版信息

J Inflamm (Lond). 2011 May 3;8:11. doi: 10.1186/1476-9255-8-11.

DOI:10.1186/1476-9255-8-11
PMID:21539730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3094202/
Abstract

The intestinal immune system and the epithelium are the first line of defense in the gut. Constantly exposed to microorganisms from the environment, the gut has complex defense mechanisms to prevent infections, as well as regulatory pathways to tolerate commensal bacteria and food antigens. Intestinal pathogens have developed strategies to regulate intestinal immunity and inflammation in order to establish or prolong infection. The organisms that employ a type III secretion system use a molecular syringe to deliver effector proteins into the cytoplasm of host cells. These effectors target the host cell cytoskeleton, cell organelles and signaling pathways. This review addresses the multiple mechanisms by which the type III secretion system targets the intestinal immune response, with a special focus on pathogenic E. coli.

摘要

肠道免疫系统和上皮细胞是肠道的第一道防线。肠道不断暴露于来自环境的微生物中,因此具有复杂的防御机制来预防感染,同时还具有调节途径来耐受共生细菌和食物抗原。肠道病原体已开发出调节肠道免疫和炎症的策略,以建立或延长感染。使用 III 型分泌系统的生物体使用分子注射器将效应蛋白递送到宿主细胞的细胞质中。这些效应物靶向宿主细胞的细胞骨架、细胞器和信号通路。本综述讨论了 III 型分泌系统靶向肠道免疫反应的多种机制,特别关注致病性大肠杆菌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4bc/3094202/6b467a13d31a/1476-9255-8-11-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4bc/3094202/d29d5d5352b2/1476-9255-8-11-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4bc/3094202/7a8b33593f30/1476-9255-8-11-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4bc/3094202/6b467a13d31a/1476-9255-8-11-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4bc/3094202/d29d5d5352b2/1476-9255-8-11-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4bc/3094202/7a8b33593f30/1476-9255-8-11-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4bc/3094202/6b467a13d31a/1476-9255-8-11-3.jpg

相似文献

1
Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system.始终领先一步:致病菌如何利用 III 型分泌系统来操纵肠道黏膜免疫系统。
J Inflamm (Lond). 2011 May 3;8:11. doi: 10.1186/1476-9255-8-11.
2
Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.共生菌(正常微生物群)、黏膜免疫与慢性炎症及自身免疫性疾病。
Immunol Lett. 2004 May 15;93(2-3):97-108. doi: 10.1016/j.imlet.2004.02.005.
3
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.
4
Shigella manipulates host immune responses by delivering effector proteins with specific roles.志贺氏菌通过传递具有特定作用的效应蛋白来操纵宿主免疫反应。
Front Immunol. 2015 May 7;6:219. doi: 10.3389/fimmu.2015.00219. eCollection 2015.
5
Shigella infection of intestinal epithelium and circumvention of the host innate defense system.志贺氏菌感染肠道上皮细胞和规避宿主先天防御系统。
Curr Top Microbiol Immunol. 2009;337:231-55. doi: 10.1007/978-3-642-01846-6_8.
6
Microbiota and Pathogen Proteases Modulate Type III Secretion Activity in Enterohemorrhagic Escherichia coli.微生物群和病原体蛋白酶调节肠出血性大肠杆菌中的 III 型分泌活性。
mBio. 2018 Dec 4;9(6):e02204-18. doi: 10.1128/mBio.02204-18.
7
Intestinal immune responses to commensal and pathogenic protozoa.肠道对共生和致病原生动物的免疫反应。
Front Immunol. 2022 Sep 16;13:963723. doi: 10.3389/fimmu.2022.963723. eCollection 2022.
8
Yersinia type III effectors perturb host innate immune responses.耶尔森氏菌Ⅲ型效应蛋白扰乱宿主固有免疫反应。
World J Biol Chem. 2016 Feb 26;7(1):1-13. doi: 10.4331/wjbc.v7.i1.1.
9
Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.由肠致病性大肠杆菌和肠出血性大肠杆菌注射的Ⅲ型分泌系统效应器诱导的紧密连接破坏
Front Cell Infect Microbiol. 2016 Aug 24;6:87. doi: 10.3389/fcimb.2016.00087. eCollection 2016.
10
Mucosal immunity to pathogenic intestinal bacteria.肠道致病菌黏膜免疫
Nat Rev Immunol. 2016 Mar;16(3):135-48. doi: 10.1038/nri.2015.17. Epub 2016 Feb 22.

引用本文的文献

1
Genetic and Virulence Characteristics of a Hybrid Atypical Enteropathogenic and Uropathogenic (aEPEC/UPEC) Strain.遗传和毒力特征的混合不典型肠致病性和尿道致病性(aEPEC/UPEC)株。
Front Cell Infect Microbiol. 2020 Sep 29;10:492. doi: 10.3389/fcimb.2020.00492. eCollection 2020.
2
A post-invasion role for type III effector TarP in modulating the dynamics and organization of host cell focal adhesions.III 型效应因子 TarP 在入侵后调节宿主细胞焦点黏附动态和组织中的作用。
J Biol Chem. 2020 Oct 23;295(43):14763-14779. doi: 10.1074/jbc.RA120.015219. Epub 2020 Aug 25.
3
Virulence gene profiles and molecular genetic characteristics of diarrheagenic from a hospital in western China.

本文引用的文献

1
A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation.肠致病性大肠杆菌的 III 型效应蛋白酶 NleC 靶向 NF-κB 进行降解。
Mol Microbiol. 2011 Apr;80(1):219-30. doi: 10.1111/j.1365-2958.2011.07568.x. Epub 2011 Feb 22.
2
Peyer's Patches: The Immune Sensors of the Intestine.派尔集合淋巴结:肠道的免疫传感器
Int J Inflam. 2010 Sep 19;2010:823710. doi: 10.4061/2010/823710.
3
NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA.NleC,一种 III 型分泌蛋白酶,通过靶向 p65/RelA 来损害 NF-κB 的激活。
中国西部某医院腹泻病原菌的毒力基因谱及分子遗传学特征
Gut Pathog. 2018 Aug 17;10:35. doi: 10.1186/s13099-018-0262-9. eCollection 2018.
4
Diarrheagenic Escherichia coli.致泻性大肠杆菌
Braz J Microbiol. 2016 Dec;47 Suppl 1(Suppl 1):3-30. doi: 10.1016/j.bjm.2016.10.015. Epub 2016 Nov 5.
5
Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.由肠致病性大肠杆菌和肠出血性大肠杆菌注射的Ⅲ型分泌系统效应器诱导的紧密连接破坏
Front Cell Infect Microbiol. 2016 Aug 24;6:87. doi: 10.3389/fcimb.2016.00087. eCollection 2016.
6
Type III Secretion-Dependent Sensitivity of Escherichia coli O157 to Specific Ketolides.大肠杆菌O157对特定酮内酯的III型分泌依赖性敏感性
Antimicrob Agents Chemother. 2015 Nov 2;60(1):459-70. doi: 10.1128/AAC.02085-15. Print 2016 Jan.
7
Distribution of non-LEE-encoded type 3 secretion system dependent effectors in enteropathogenic Escherichia coli.非LEE编码的3型分泌系统依赖性效应蛋白在肠致病性大肠杆菌中的分布
Braz J Microbiol. 2014 Oct 9;45(3):851-5. doi: 10.1590/s1517-83822014000300014. eCollection 2014.
8
Effect of HIV and chlamydia infection on rectal inflammation and cytokine concentrations in men who have sex with men.人类免疫缺陷病毒(HIV)和衣原体感染对男男性行为者直肠炎症及细胞因子浓度的影响。
Clin Vaccine Immunol. 2013 Oct;20(10):1517-23. doi: 10.1128/CVI.00763-12. Epub 2013 Jul 31.
9
Gut homeostasis in a microbial world: insights from Drosophila melanogaster.微生物世界中的肠道内稳态:来自黑腹果蝇的启示。
Nat Rev Microbiol. 2013 Sep;11(9):615-26. doi: 10.1038/nrmicro3074. Epub 2013 Jul 29.
10
Animal models of enteroaggregative Escherichia coli infection.肠聚集性大肠杆菌感染的动物模型。
Gut Microbes. 2013 Jul-Aug;4(4):281-91. doi: 10.4161/gmic.24826. Epub 2013 May 2.
PLoS Pathog. 2010 Dec 16;6(12):e1001231. doi: 10.1371/journal.ppat.1001231.
4
The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold.细菌催化支架组装 GTPase-激酶信号复合物。
Nature. 2011 Jan 6;469(7328):107-11. doi: 10.1038/nature09593. Epub 2010 Dec 19.
5
Proteasome-independent degradation of canonical NFkappaB complex components by the NleC protein of pathogenic Escherichia coli.致病性大肠杆菌 NleC 蛋白导致经典 NF-κB 复合物成分的蛋白酶体非依赖性降解。
J Biol Chem. 2011 Feb 18;286(7):5100-7. doi: 10.1074/jbc.M110.172254. Epub 2010 Dec 9.
6
Metalloprotease type III effectors that specifically cleave JNK and NF-κB.III 型金属蛋白酶效应子,特异性切割 JNK 和 NF-κB。
EMBO J. 2011 Jan 5;30(1):221-31. doi: 10.1038/emboj.2010.297. Epub 2010 Nov 26.
7
Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation.肠致病性大肠杆菌非 LEE 编码效应物 NleH1 和 NleH2 可减弱 NF-κB 的激活。
Mol Microbiol. 2010 Dec;78(5):1232-45. doi: 10.1111/j.1365-2958.2010.07400.x. Epub 2010 Oct 15.
8
Pathogenic bacteria target NEDD8-conjugated cullins to hijack host-cell signaling pathways.致病细菌靶向 NEDD8 连接的 cullin 以劫持宿主细胞信号通路。
PLoS Pathog. 2010 Sep 30;6(9):e1001128. doi: 10.1371/journal.ppat.1001128.
9
The immune system and the gut microbiota: friends or foes?免疫系统与肠道微生物群:是朋友还是敌人?
Nat Rev Immunol. 2010 Oct;10(10):735-44. doi: 10.1038/nri2850.
10
Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE.肠道致病性大肠杆菌效应蛋白NleE对人树突状细胞中NF-κB信号通路的抑制作用。
J Immunol. 2010 Oct 1;185(7):4118-27. doi: 10.4049/jimmunol.1000500. Epub 2010 Sep 10.